Investment
Features
FeesSafety
Academy
More
Pluang+

Boralex secures all regulatory approvals for its arrangement with Brookfield and La Caisse, expected to close mid-August.

Company Fundamentals
06 Aug 2026
Boralex Inc.
View Source
Bullish
pluang ai news

Boralex Inc. has received all necessary regulatory approvals for its previously announced arrangement with Brookfield and La Caisse. The arrangement, approved by shareholders and the Quebec Superior Court, is expected to close around August 14, 2026, pending final conditions. This deal marks a significant step for Boralex, a leader in renewable energy, as it continues to expand its capacity and project portfolio across North America and Europe. The company emphasizes its commitment to renewable energy and corporate social responsibility throughout this transition.

More News

A'cappella Chocolate's Maple Glazed Donut Crisps now sold at 50 California Costcos and online delivery.

A'cappella Chocolate's Maple Glazed Donut Crisps now sold at 50 California Costcos and online delivery.

A'cappella Chocolate, a California-based snack maker, has launched its Maple Glazed Donut Crisps in 50 Costco warehouses across California. These crisps are made from fresh donut dough pressed into thin chips with a maple glaze, offering a snackable ...

Others
Bullish
21 minutes ago
Bercor launches Bercor Pay, a global USD Visa card with transparent fees and Apple/Google Pay support.

Bercor launches Bercor Pay, a global USD Visa card with transparent fees and Apple/Google Pay support.

Bercor has introduced Bercor Pay, a USD Visa card designed for global consumers who frequently spend across borders. Launched on July 29, 2026, the card offers acceptance at millions of Visa merchants worldwide, supports Apple Pay and Google Pay, and...

Others
Bullish
1 hour ago
Biogen completes acquisition of RayThera, advancing immunology pipeline with Phase 1 lead program

Biogen completes acquisition of RayThera, advancing immunology pipeline with Phase 1 lead program

Biogen has finalized its acquisition of RayThera Inc., a biotech company specializing in small-molecule therapies for immunology. This deal strengthens Biogen’s immunology portfolio by adding multiple assets aimed at treating immune-related condition...

Company Fundamentals
Bullish
1 hour ago
Redwire stock jumps 11% after beating Q2 earnings and raising price target to $16.

Redwire stock jumps 11% after beating Q2 earnings and raising price target to $16.

Redwire Corporation reported better-than-expected Q2 results with a smaller loss of $0.09 per share and sales of $117 million, surpassing analyst estimates. The company achieved a record gross profit margin of 27.8% and a strong $542.1 million backlo...

Company Fundamentals
Bullish
1 hour ago
Digi International jumps on strong Q3 IoT growth and raised price target to $90

Digi International jumps on strong Q3 IoT growth and raised price target to $90

Digi International reported strong Q3 results with earnings of $0.75 per share and revenue of $138.67 million, beating estimates. The company saw 29% revenue growth, a record adjusted EBITDA of $40 million, and $191 million in annual recurring revenu...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App